beta-lactams has been researched along with cefuroxime in 28 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cefuroxime) | Trials (cefuroxime) | Recent Studies (post-2010) (cefuroxime) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 2,313 | 517 | 502 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 5 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Hofstra, H; van der Waaij, D; Wiegersma, N | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Baker, S; Cadge, B; Durham, SR; Gillett, AP; Wise, R | 1 |
| Andrews, JM; Brenwald, N; Wise, R | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C | 1 |
| Alefelder, M; Arvis, P; Berg, O; Gehanno, P; Leiberman, A; Martinkenas, JL; Nikolaidis, P; Reimnitz, P; Siegert, R | 1 |
| Dalhoff, A; Nasu, T; Okamoto, K | 1 |
| Buszman, E; Misiołek, M; Namysłowski, G; Namysłowski, W | 1 |
| Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J | 1 |
| Aguilar, L; Alou, L; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Charlier, C; Denooz, R | 1 |
| Chan, HW; Chan, KC; Chan, PH; Chung, WH; Lai, TS; Leung, YC; Ma, DL; Siu, FM; So, PK; Tsang, CW; Wong, KY; Yiu, KF; Zhao, Y | 1 |
| Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
| Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Baum, MM; Guerrero-Given, D; Gunawardana, M; Li, X; Maguire, K; Schaudinn, C; Wang, C; Webster, P; Wu, S | 1 |
| Carlson, EE; Kocaoglu, O | 1 |
| Bentin, T; Givskov, M; Goltermann, L; Thorsing, M; Tolker-Nielsen, T | 1 |
| Gennimata, D; Kiriazopoulos, E; Lombardo, K; Panderi, I; Panteri-Petratou, E; Vonaparti, A; Vourna, P; Zaharaki, S | 1 |
| Branda, JA; Hovius, JW; Hu, LT; Li, X; Mead, PS; Steere, AC; Strle, F; Wormser, GP | 1 |
| Bruch, R; Chatelle, C; Dincer, C; Kling, A; Rebmann, B; Schumann, S; Urban, G; Weber, W; Wirth, S | 1 |
| Cha, HJ; Jeong, JH; Kim, YG | 1 |
| Chan, EWC; Chan, KF; Chan, TH; Chen, S; Cheung, KC; Chiou, J; Gao, W; Jin, WB; Kan, JWY; Leung, YC; Lin, D; Lui, HK; Sun, N; Wong, ILK; Wong, KY | 1 |
| Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
| Dartois, V; Dick, T; Negatu, DA; Zimmerman, MD | 1 |
| Bayer, AS; Cavaco, G; Chambers, HF; Cheung, A; Ersoy, SC; Gonçalves, B; Manna, AC; Nast, CC; Proctor, RA; Sobral, RG | 1 |
| Helmann, JD; Patel, Y; Rhee, KY; Soni, V | 1 |
| Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J | 1 |
1 review(s) available for beta-lactams and cefuroxime
| Article | Year |
|---|---|
Lyme borreliosis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Borrelia burgdorferi; Borrelia burgdorferi Group; Cefuroxime; Doxycycline; Exanthema; Humans; Ixodes; Lyme Disease; Lyme Neuroborreliosis; Risk Factors; Zoonoses | 2016 |
3 trial(s) available for beta-lactams and cefuroxime
| Article | Year |
|---|---|
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Female; Humans; Lactams; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Treatment Outcome | 2003 |
[Evaluation of microorganisms ability to beta-lactamase production in exacerbation of chronic sinusitis treated with beta-lactam antibiotics].
Topics: beta-Lactamases; beta-Lactams; Cefuroxime; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Sinusitis | 2003 |
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Sinusitis; Time Factors | 2006 |
24 other study(ies) available for beta-lactams and cefuroxime
| Article | Year |
|---|---|
Effect of beta-lactam antibiotics of the resistance of the digestive tract of mice to colonization.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Cefuroxime; Cephamycins; Dose-Response Relationship, Drug; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Feces; Female; Intestines; Mezlocillin; Mice; Moxalactam; Penicillins | 1982 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Blister; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Floxacillin; Humans; Imidazolidines; Male; Penicillins; Protein Binding | 1980 |
In vitro activity of the tricyclic beta-lactam GV104326.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefuroxime; Ciprofloxacin; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae | 1996 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
Topics: Acute Disease; Amoxicillin; beta-Lactam Resistance; beta-Lactams; Cefpodoxime; Ceftizoxime; Cefuroxime; Erythromycin; France; Humans; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Penicillins; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Binding Sites; Carrier Proteins; Cefuroxime; Dose-Response Relationship, Drug; Enterobacteriaceae; Enzyme Stability; Escherichia coli Proteins; Gram-Positive Cocci; Hexosyltransferases; Imipenem; In Vitro Techniques; Lactams; Microscopy, Electron, Scanning; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Serine-Type D-Ala-D-Ala Carboxypeptidase | 2003 |
Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefuroxime; Cephalosporins; Computer Simulation; Drug Resistance, Bacterial; Haemophilus influenzae; Half-Life; Kinetics; Microbial Sensitivity Tests; Phenotype | 2007 |
Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cefuroxime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Meropenem; Piperacillin; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Thienamycins | 2008 |
Fluorophore-labeled beta-lactamase as a biosensor for beta-lactam antibiotics: a study of the biosensing process.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biosensing Techniques; Cefuroxime; Circular Dichroism; Computer Simulation; Fluoresceins; Fluorescent Dyes; Kinetics; Mass Spectrometry; Models, Molecular; Penicillanic Acid; Penicillin G; Protein Denaturation; Spectrometry, Fluorescence | 2008 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefuroxime; Cephalosporins; Coculture Techniques; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Selection, Genetic | 2009 |
Beta- lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Biofilms; Biomass; Carbohydrate Metabolism; Cefuroxime; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Haemophilus influenzae; Humans; Transformation, Bacterial; Up-Regulation | 2014 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Escherichia coli strain DC2.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefotaxime; Cefuroxime; Escherichia coli; Microbial Sensitivity Tests; Penicillin-Binding Proteins | 2015 |
The bactericidal activity of β-lactam antibiotics is increased by metabolizable sugar species.
Topics: Anti-Bacterial Agents; Bacteriolysis; beta-Lactams; Carbenicillin; Carbohydrate Metabolism; Carbohydrates; Cefuroxime; Drug Synergism; Escherichia coli; Flow Cytometry; Microbial Viability; Microscopy | 2015 |
Quantification of three beta-lactam antibiotics in breast milk and human plasma by hydrophilic interaction liquid chromatography/positive-ion electrospray ionization mass spectrometry.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cefuroxime; Chromatography, Liquid; Female; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Milk, Human; Spectrometry, Mass, Electrospray Ionization | 2017 |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefuroxime; Drug Monitoring; Female; Humans; Male; Microfluidic Analytical Techniques; Piperacillin; Point-of-Care Testing; Precision Medicine | 2017 |
Crystal Structures of Penicillin-Binding Protein D2 from Listeria monocytogenes and Structural Basis for Antibiotic Specificity.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cefotaxime; Cefuroxime; Crystallography, X-Ray; Humans; Listeria monocytogenes; Penicillin G; Penicillin-Binding Proteins | 2018 |
Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor.
Topics: Animals; Bacterial Proteins; beta-Lactams; Binding Sites; Cefuroxime; Cytoskeletal Proteins; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Mice; Small Molecule Libraries; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus | 2022 |
Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCO
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cefuroxime; Cell Wall; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Sodium Bicarbonate; Staphylococcus aureus; Teichoic Acids | 2022 |
Mutations in
Topics: Acetylglucosamine; Antitubercular Agents; Bacterial Proteins; beta-Lactams; Cefuroxime; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Peptidoglycan; Rifampin; Uridine Diphosphate | 2023 |
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Methicillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2023 |